In a new study, researchers at Lund University and Uppsala University have seen a clear connection between how long a person sleeps and a number of biomarkers linked to cardiometabolic diseases such as cardiovascular disease and type 2 diabetes. “With greater knowledge of the actual mechanisms of disease development, the possibilities for a more specific and targeted treatment increase”, says…
Alongside the worldwide increase in longevity, inevitably with chronic health conditions rising, cardiovascular procedures and OR utilisation have surged. Thus the efficient and safe performance of surgeries is even more important. The intraoperative use of mobile C-arms increases accuracy, improving clinical outcomes, which can significantly reduce revision rates and thus overall healthcare…
Women remain underrepresented in cardiovascular clinical trials despite guidelines and legal requirements developed almost 30 years ago to ensure broader inclusivity. This is according to a report from the American College of Cardiology Cardiovascular Disease in Women Committee published in the Journal of the American College of Cardiology. This lack of representation can limit availability of…
Efforts to understand cardiac disease progression and develop therapeutic tissues that can repair the human heart are just a few areas of focus for the Feinberg research group at Carnegie Mellon University. The group's latest dynamic model, created in partnership with collaborators in the Netherlands, mimics physiologic loads on engineering heart muscle tissues, yielding an unprecedented view of…
Medical monitoring tech company Umana Medical announced a collaboration with the Preventive Cardiology and Medical Prevention, Center of Cardiology at the University Medical Center Mainz and Bayer AG on a clinical study (MyoMobile study) to explore a novel real-time remote cardiac monitoring device in patients with heart failure.
Medical robotics company Robocath and Rennes University Hospital announce the launch of a co-development research program using robotics to improve treatment for stroke victims. With the support of Philips France, this program will be implemented over the next four years. It will focus on the use of robotics in treating strokes, the second most common cause of death globally after myocardial…
Nanoelectronics and digital technologies company Imec presents a proof-of-concept for determining arterial stiffness, a risk marker for cardiovascular diseases such as stroke and heart failure, and monitoring blood pressure. Imec’s approach uses an ultrasound sensor to measure the central pulse wave velocity. Measuring pulse wave velocity closer to the heart is also a more reliable proxy for…
Women are missing out on appropriate cardiac care because guidelines and medications often fail to take into account gender and conditions that specifically affect the female population. Women are also underrepresented in clinical trials for new cardiac therapies.
Researchers funded by the British Heart Foundation (BHF) have developed biodegradable microspheres that can be used to deliver heart cells generated from stem cells to repair damaged hearts after a heart attack, in research presented at the British Cardiovascular Society conference.
For the first time, a prospective, international study has shown that chest pain caused by problems with the very small vessels supplying blood to the heart is an important health problem that increases the risk of heart attacks, stroke and death due to cardiovascular reasons. The study, which is published in the European Heart Journal, recruited 686 patients from 14 institutions in seven…
Self-organizing heart organoids – developed at the Austrian Academy of Sciences – are also effective injury- and in vitro congenital disease models. These “cardioids” may revolutionize research into cardiovascular disorders and malformations of the heart. The results are published in the journal Cell.
Activity monitors via phones and bracelets help to assess exercise but experts question which device may really stimulate activity in cardiovascular patients, and which might be best for research? Three types of activity monitors exist: uniaxial, which measure acceleration in one plane; biaxial and triaxial, which measure acceleration in two or three planes; and multisensory activity monitors,…
A new research project will embrace the combination of 5G telecommunications technology and AI to offer continuous remote monitoring to seriously ill heart failure patients. An increasing number of chronic heart failure patients are receiving Left Ventricular Assist Devices (LVADs) to help them live with their condition, but physicians acknowledge the need to effectively monitor them.
Omega-3 supplements are associated with an increased likelihood of developing atrial fibrillation in people with high blood lipids. That’s the finding of a study published in European Heart Journal - Cardiovascular Pharmacotherapy, a journal of the European Society of Cardiology (ESC).
A major study from the Washington University School of Medicine details numerous long-term effects of COVID-19, pointing to massive health burden.
Kobe University Hospital’s Dr. Makoto Nishimori and Project Assistant Professor Kunihiko Kiuchi et al. (of the Division of Cardiovascular Medicine, Department of Internal Medicine) have developed an AI that uses multiple kinds of test data to predict the location of surplus pathways in the heart called ‘accessory pathways’, which cause the heart to beat irregularly. In this study, the…
Thanks to extended permissions obtained from the Civil Aviation Authority (CAA) in Sweden, autonomous drone company Everdrone will soon provide 200,000 people in Sweden with access to emergency medical deliveries of Automated External Defibrillators (AEDs) by drone as Everdrone expands operations outside the Gothenburg region.
In a recent study by University of Alabama at Birmingham researchers, findings indicate that among patients with heart failure, obesity is associated with a higher risk of heart failure hospitalization or death due to cardiac causes. However, achieving biomarker-based treatment goals in heart failure improves the prognosis for patients irrespective of their obesity status.
With the first-in-man implantation of the Berlin Heart Venous Cannula at the LMU University Hospital Munich, Germany, Berlin Heart offers patients with a failing Fontan circulation a unique chance to survive the waiting time for a donor heart. These patients are in a life-threatening condition: their health has deteriorated so much that they desperately need a new heart, but because of their poor…
